Abstract:Purpose/Objective(s) Radiotherapy (RT) for head and neck cancer (HNC) is associated with multiple late toxicities and may be a potential driver of accelerated atherosclerosis and a higher risk of carotid artery stenosis (CAS), cerebrovascular and cardiovascular diseases. To date, feasibility, acceptability, and clinical utility of carotid artery ultrasound (CUS) imaging as a part of HNC survivorship has not been studied prospectively. Materials/Methods In this study (NCT05490875), 60 patients who completed RT for HNC at least 2 years prior with no evidence of disease will be enrolled. Patients with a history of CAS, stroke, transient ischemic attack, carotid endarterectomy, carotid stent, prior CUS, recurrent HNC, re-irradiation, or ECOG 2+ will be excluded. Eligible patients will undergo a CUS with assessment of peak systolic velocity, measurement of bilateral carotid intima-media thickness (IMT), and evaluation for luminal diameter narrowing/occlusion and/or carotid plaque. An IMT-based relative risk of cardiovascular disease will be calculated. After the CUS, surveys assessing the acceptability of/barriers to CUS, as well as perceived stroke risk will be obtained. At 3- and 6-months after CUS, patients will be contacted to determine if any changes to their medical care have occurred since the CUS. Lipid profiling and high-sensitivity C-reactive protein (CRP) will be performed. The results of the CUS will be made available to the patient, their primary care provider, and their HNC physicians; if any abnormality (including clinically significant CAS) is detected, a referral for formal evaluation will be made. Results The study opened in October 2022 and has accrued 22/60 patients. The primary objective is to determine the proportion of patients with clinically significant CAS in HNC survivors treated with RT. Secondary objectives include: measure bilateral carotid IMT, determine the risk of CAS based on baseline clinical/treatment factors, and obtain preliminary data on feasibility, acceptability, barriers to care, and perceptions of stroke risk. We will also determine the proportion of patients with high cardiovascular risk based on IMT and plaque presence. Exploratory objectives include determining the proportion of patients with abnormal CUS findings with actionable interventions (e.g., consultations, medications, procedures) and correlating carotid IMT measurements with RT dose to the carotid artery. Planned translational analyses include correlation of CUS findings with CT-based measurements of carotid calcification, peripheral blood mononuclear cell bioenergetics, metabolomic/lipidomic signatures, and serum cytokine profiles. Conclusion This study will provide preliminary data on the feasibility, acceptability and expected proportion of clinically actionable findings in patients who undergo screening CUS in survivorship after RT for HNC.

Hypothyroidism and risks of cerebrovascular complications among patients with head and neck cancer after radiotherapy

Carotid Artery Stenosis and Ischemic Stroke in Patients with Head and Neck Cancer Treated with Radiotherapy: A Critical Review

Correlation between thyroid autoantibodies and intracranial arterial stenosis in stroke patients with hyperthyroidism.

Radiation Dose-Induced Carotid Artery Stenosis and Brain Necrosis in Head and Neck Cancer—A Real World Cohort Study

Increased risk of cerebrovascular mortality in head and neck cancer survivors aged ≥ 65 years treated with definitive radiotherapy: a population-based cohort study

Vascular events from carotid artery atherosclerosis after radiation therapy for laryngeal and hypopharyngeal cancer: the incidence and risk factors

The Impact of De-Escalated Radiotherapy on Carotid Stenosis Rates in Head and Neck Cancer Patients

Analysis of correlative risk factors for radiation-induced hypothyroidism in head and neck tumors

Radiation-Induced Hypothyroidism in Patients With Breast Cancer After Hypofractionated Radiation Therapy: A Prospective Cohort Study

Incidence of Carotid Blowout Syndrome in Patients with Head and Neck Cancer after Radiation Therapy: A Cohort Study

An Underdiagnosed Hypothyroidism and Its Clinical Significance in Patients with Advanced Hepatocellular Carcinoma.

Assessing radiation-induced carotid artery injury using ultrasound in patients with head and neck cancer

Thyroid function following radiation therapy in breast cancer patients: risk of radiation-induced hypothyroidism

Vertebral artery stenosis predicts cerebrovascular diseases following radiotherapy for nasopharyngeal carcinoma

A prospective clinical study to assess primary hypothyroidism in head and neck cancer patients treated with external beam radiotherapy

Relative Risk of Stroke in Head and Neck Carcinoma Patients Treated With External Cervical Irradiation

Research progress of radiation-induced hypothyroidism in head and neck cancer

Relationship Of Thyroid Function With Intracranial Arterial Stenosis And Carotid Atheromatous Plaques In Ischemic Stroke Patients With Euthyroidism

Early screening of high-risk patients with radiation-induced hypothyroidism in nasopharyngeal carcinoma by hematological examination

A Pilot Study of Carotid Ultrasound to Identify Head and Neck Cancer Survivors with High Cardiovascular Risk after Radiation Therapy

Progression rate of radiation-induced carotid stenosis in head and neck cancer survivors after statin treatment: a retrospective cohort study